Skye Bioscience, Inc. (SKYE)
Total Valuation
SKYE has a market cap or net worth of $1.51 billion. The enterprise value is $1.51 billion.
| Market Cap | 1.51B |
| Enterprise Value | 1.51B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SKYE has 971.55 million shares outstanding. The number of shares has increased by 297.27% in one year.
| Shares Outstanding | 971.55M |
| Shares Change (YoY) | +297.27% |
| Shares Change (QoQ) | +102.78% |
| Owned by Insiders (%) | 18.26% |
| Owned by Institutions (%) | 0.21% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 888.30 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19, with a Debt / Equity ratio of 2.61.
| Current Ratio | 0.19 |
| Quick Ratio | 0.44 |
| Debt / Equity | 2.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.90 |
Financial Efficiency
Return on equity (ROE) is -2,584.07% and return on invested capital (ROIC) is -652.31%.
| Return on Equity (ROE) | -2,584.07% |
| Return on Assets (ROA) | -280.73% |
| Return on Capital (ROIC) | -652.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.98M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SKYE has paid $987,206 in taxes.
| Income Tax | 987,206 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8,757.14% in the last 52 weeks. The beta is 0.91, so SKYE's price volatility has been similar to the market average.
| Beta (1Y) | 0.91 |
| 52-Week Price Change | +8,757.14% |
| 50-Day Moving Average | 2.40 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 40.53 |
| Average Volume (30 Days) | 213,738 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -39.93M |
| Pretax Income | -43.11M |
| Net Income | -43.81M |
| EBITDA | -13.95M |
| EBIT | -14.08M |
| Earnings Per Share (EPS) | -$10.51 |
Balance Sheet
The company has $5.13 million in cash and $4.43 million in debt, giving a net cash position of $699,896 or $0.00 per share.
| Cash & Cash Equivalents | 5.13M |
| Total Debt | 4.43M |
| Net Cash | 699,896 |
| Net Cash Per Share | $0.00 |
| Equity / Book Value | 1.70M |
| Book Value Per Share | 0.00 |
| Working Capital | -7.92M |
Cash Flow
In the last 12 months, operating cash flow was -$14.98 million and capital expenditures -$18,037, giving a free cash flow of -$15.00 million.
| Operating Cash Flow | -14.98M |
| Capital Expenditures | -18,037 |
| Free Cash Flow | -15.00M |
| FCF Per Share | -$1.90 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SKYE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -2.91% |
| FCF Yield | -1.00% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -297.27% |
| Shareholder Yield | -297.27% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 8, 2023. It was a reverse split with a ratio of 1:250.
| Last Split Date | Sep 8, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:250 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |